MorphoSys' Licensing Partner Roche Provides Update on Phase

14.11.2022 - GRADUATE studies did not meet primary endpointPLANEGG / MUNICH, GERMANY / ACCESSWIRE / November 14, 2022 / MorphoSys AG (FSE:MOR)(NASDAQ:MOR) announced today that its licensing partner Roche (SIX: RO, ROG; OTCQX: RHHBY) provided an update on the ... Seite 1

Related Keywords

Planegg , Bayern , Germany , Jean Paul Kress , Ihre Einstellungen , Constellation Pharmaceuticals Inc , Chief Executive Officer , Clinical Trials , Constellation Pharmaceuticals , Kurserwartungen Des Analysten , Sie Kursziel , Emittent Alternativ , Morphosys ,